Fig. 1From: A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infectionFDA approval timeline of INSTI single and fixed dose combination products used for HIV-1 treatment and prevention *discontinued, 3TC lamivudine, ABC abacavir, COBI cobicistat, FTC emtricitabine, HD high dose, RPV rilpivirine, TAF tenofovir alafenamide, TDF tenofovir disoproxil fumarateBack to article page